Nonprofit Diabetes Focus Tidepool is a 501(c)3 nonprofit dedicated to making diabetes data accessible and actionable for patients, care teams, and researchers. This indicates potential partnerships with healthcare providers, patient advocacy groups, and research institutions to expand data sharing, interoperability, and collaborative studies.

Interoperable Diabetes Initiatives Tidepool Loop aims to create an FDA-regulated interoperable automated insulin delivery system working with commercially available pumps and CGMs. For sales opportunities, target glucose monitor and insulin pump manufacturers, regulatory consultants, and clinics exploring interoperable, standards-based solutions.

Partnership & Collaboration Historically, Tidepool has formed partnerships with Medtronic, Ōura, Embecta, HealthPartners, and others to scale reporting, data integration, and automated delivery workflows. Identify opportunities to offer data platform enhancements, consulting, or co-developed modules with these or similar ecosystem players.

Data Platform Growth Tidepool added Ambulatory Glucose Profile (AGP) to its data platform and emphasizes open source software. This suggests demand for analytics add-ons, custom dashboards, real-time data streams, and professional services around data normalization, reporting templates, and research-grade exports.

Scale & Outreach With a revenue range of 50-100 million and a mid-size employee base, Tidepool is positioned for broader adoption via healthcare institutions and research networks. Sales plays could target large clinics, university centers, and health plans seeking standardized diabetes data workflows and patient data interoperability at scale.